Global Medtech Executive Recruitment : Start-up -> Fortune 500 : IC -> C-Level : Emerging Medtech Trends & Insights
🩻💵 Great news for the team at Evident Vascular, Inc. out of San Jose, CA as they secure Series B #financing toward their AI-enabled #intravasuclar #ultrasound (IVUS) platform. Evident Vascular, Inc. is developing a very novel and innovative solution to combat #arterial and #deepvenous disease integration advanced AI models into intravascular ultrasound #imaging to empower #vascular interventionists with an enriched image interpretation to better understand each patient's unique #disease state. This latest round on #medtech #funding comes by way of ShangBay Capital as well as private investing partners with earmark toward further development and upcoming FDA 510(k) submission. “This significant investment underscores our investors’ confidence in Evident Vascular, Inc.'s mission and technology while highlighting the vital role of intravascular imaging in optimizing patient outcomes, clinical decision-making and procedural success. We will accelerate our progress toward FDA clearance and further the development of our AI-powered IVUS solution, which aims to set a new standard in vascular image guided therapy.” - Howard Rosen, Evident Vascular, Inc. CEO & Co-Founder #medtech / #medicaldevice / #vascularimaging / #aihealthcare / #medtechfunding / The Mullings Group / MassDevice / Sean Whooley
Wesley Kennedy-Sita, Congrats to the team at Evident Vascular on securing Series B financing! It’s exciting to see how your AI-enabled IVUS platform can make such a difference in patient care. Looking forward to seeing how this technology develops! What are the next steps for your team as you move toward FDA clearance? 🚀💡 #HealthcareInnovation #AIinMedicine